Objective: We have previously characterized the reproductive hormone profile in infertile women with diminished ovarian reserve (DOR) as being distinct from that seen in age-comparable healthy controls. Hypothesizing that DOR reflects accelerated reproductive aging, we herein compare urinary reproductive hormone dynamics between young women with DOR and a population of chronologically older perimenopausal controls.
T he concept of Bovarian reserve[ is a relatively recent appreciation within the continuum of reproductive aging and alludes to the number of remaining oocytes in any premenopausal female at a given age. 1, 2 Although ovarian reserve assessment is routinely undertaken in the context of infertility workup, this concept remains relatively underappreciated in the primary care setting. Premenopausal women diagnosed with diminished ovarian reserve (DOR) are without clinical stigmata other than subfertility. Indeed, covert biomarkers and suboptimal quantitative and qualitative responses to attempts at ovarian stimulation during fertility treatment are the hallmarks of DOR in otherwise asymptomatic women. 3 Despite strides in infertility management over recent years, suboptimal reproductive successes are recognized in women with DOR. 4<7 Recent studies have demonstrated an increased likelihood of early menopause in infertile women manifesting features of DOR, 8<10 suggesting an acceleration of the process of reproductive aging in at least a subset of these young women. 11 In a study of reproductive hormones in daily morning urine specimens collected over a spontaneous menstrual cycle, we had previously observed that the urinary reproductive hormone profiles in young women with DOR are distinct from those in age-comparable controls. 9 Significantly prolonged gonadotropin (follicle-stimulating hormone [FSH] and luteinizing hormone [LH]) surges and significantly attenuated luteal excretion of estrogen and progesterone metabolites were noted in women with DOR compared with age-comparable controls. 9 Hypothesizing that DOR reflects accelerated reproductive aging, we herein compare urinary reproductive hormone dynamics between young women with DOR and a sample of chronologically older controls. Our analyses identify the reproductive hormone milieu of DOR as being distinct from that of chronologically advanced perimenopause.
METHODS
Participants identified with DOR collected daily first morning-voided urine over an entire menstrual cycle, as was previously described. 9 The study was approved by the institutional review board at the Albert Einstein College of Medicine and Montefiore Medical Center. Daily morning urine samples were available from a historical cohort of perimenopausal controls, also as was previously described. 10 Of note, informed consent was available for all controls for use of data in future studies.
DOR cases
Daily urinary reproductive hormone data were available for eight healthy, regularly cycling (21-35 d) infertile women (age range, 32-37 y). 9 DOR was diagnosed by (1) early follicular (cycle days 1-3) serum FSH concentration of greater than 10 mIU/ mL (as per practice standard for the institution) and (2) suboptimal ovarian response to previous attempts at ovarian hyperstimulation (G3 dominant follicles after utilization of gonadotropins in excess of 300 U/d). Women with an abnormal serum level of prolactin, thyroid functions, or chronic diseases were excluded.
Perimenopausal controls
Previously reported urinary reproductive hormone data 10 for 11 healthy regularly cycling, perimenopausal normoprolactinemic and euthyroid historical controls were used for comparison.
Specimen collection
Details on specimen collection procedures have been published previously. 9, 10 Briefly, the participants were asked to collect a first morning-voided urine specimen in supplied containers and transfer a portion of the volume in the polypropylene tubes provided up to the specified mark; the tubes were prefilled with glycerol (final concentration of 7% glycerol was achieved in the collected urine sample). 9,10 Glycerolpreserved specimens were used for all assays, because this has been reported to permit the measurement of LH and FSH over long storage intervals and does not interfere with estrone conjugate (E1c) or progesterone metabolite pregnanediol glucuronide (Pdg) assay. 11<14 The participants were instructed to store the tubes within the home freezer in a box provided. Specimens were transported to the laboratory at the end of the collection period and stored at j20-C. 9,10 All participants were provided with written instructions regarding the procedure of collection and storage of urine samples over an entire menstrual cycle (first day of menses to the first day of next menstrual flow).
Hormone assays
Urinary LH and FSH were measured using a solidphase, two-site-specific fluoroimmunometric assay (DELFIA; PerkinElmer, Turku, Finland) and were validated in our laboratory using previously described methods. 9, 10, 14 For urinary LH, interassay and intra-assay coefficients of variation (CV) were 13.7% and 5.0%, respectively, and were 16.4% and 7.6% for FSH, respectively. E1c and Pdg were measured in duplicate by an enzyme-linked immunosorbent assay using antibodies and conjugate tracers provided by Dr. Bill Lasley (University of California, Davis, CA). 14, 15 The interassay CV for E1c was 10.1%, and the intra-assay CV was 8.4%. Corresponding CVs for Pdg were 15.0% and 14.0%, respectively. Urinary hormone concentrations were adjusted for glycerol and normalized to urinary creatinine (Cr). 16 A portion of the historical samples of the control group were assayed concurrently with those from the experimental group, as a quality control measure to ensure against assay drift on the available stored control samples. Cycles were centralized to the day of the LH surge (day 0), which was defined using established statistical methods. 10 The presence of luteal activity was determined by a sustained increase in Pdg concentrations of 3 Kg/mg Cr or greater for 3 consecutive days. Days j14 to j1 (inclusive) identified the follicular phase, whereas days j14 to j6, excluding day j6, defined the early follicular phase. The luteal phase was defined as days +2 to +14 (inclusive). Luteal phase adequacy was defined as any day on which urinary Pdg exceeded 3 Kg/mg Cr. 9
Data analyses
Data were organized into Microsoft Excel spreadsheets and inspected for error and completeness. The duration of LH and FSH surges was defined as the number of days of persistent elevation in the respective gonadotropin levels above a threshold of a 3-SD increase from a follicular phase nadir baseline, which was calculated using a 5-day moving average. 17 The integrated urinary excretion of the individual urinary hormones was evaluated for participants with DOR and the healthy perimenopausal controls. Hormone levels for the early follicular and the entire follicular and luteal phases as well as for the LH and FSH surges in the two groups were compared. The levels of E1c on day j1, that is, the day before LH surge; the duration of LH and FSH surge (in days); and the duration of adequacy of luteal phase were similarly assessed in the two groups. Area-under-the-curve analyses were calculated using Prism 4.0 (GraphPad Software, La Jolla, CA) for comparison. All comparisons were made using a nonparametric Mann-Whitney U test because of a non-Gaussian distribution of the hormone data. SPSS 16.0 (SPSS Inc., Chicago, IL) was used for analyses, and P G 0.05 was considered as statistically significant.
(age range, 32-37 y) and 11 perimenopausal historical controls (age range, 43-52 y). One woman with DOR failed to provide urine samples beyond cycle day 16 (2 d after the LH surge) and thus was excluded from analysis evaluating the duration of LH and FSH surges and luteal Pdg levels. All participants displayed adequate FSH and LH surges. All perimenopausal controls and seven of the DOR participants exhibited luteal activity as reflected by predefined urinary Pdg excursions (excluding the one DOR participant who failed to provide post-LH surge urine samples).
Although an early follicular phase FSH level of greater than 10 mIU/ mL was a diagnostic criterion for DOR (as specified in BMethods[), the early follicular urinary FSH levels were significantly lower in the DOR group compared with the older perimenopausal population (P G 0.001, Fig. 1 ). The midcycle urinary FSH surge was comparable in the two groups, both in amplitude and in duration ( Table 1) . LH surge, however, was significantly exaggerated in the DOR, in both amplitude and duration, compared with the older perimenopausal cohort ( Table 1 ; Fig. 2 ).
As is demonstrated in Figure 3 and Table 1 , significantly attenuated urinary E1c levels, both in the follicular and the luteal phases of the cycle, were observed in the DOR group compared with the perimenopausal older controls. The presurge E1c level was lower in premenopausal women with DOR compared with the older perimenopausal group, and this difference approached statistical significance (P = 0.062). Although, the luteal urinary Table 1 for details). Note: centering of cycles relative to the LH surge (day 0). E1c, estrogen conjugate; LH, luteinizing hormone; DOR, diminished ovarian reserve.
Pdg levels were lower and the duration of luteal phase adequacy shorter in young women with DOR compared with the older perimenopausal controls, these differences were not statistically significant ( Table 1 ; Fig. 4 ).
DISCUSSION
We had previously described the distinctions in the reproductive hormone milieu of infertile women with DOR compared with healthy reproductive-aged controls with normal ovarian reserve. 9 Our current study extends our earlier observations and identifies the distinctions between DOR and chronologically advanced perimenopause. DOR is thus appreciated as a distinct entity in the paradigm of reproductive aging. Elevation in FSH is a recognized hallmark of reproductive aging 18<20 and is appreciated concomitantly with declining ovarian reserve. Gonadal signals such as inhibin, activin, and follistatin are recognized modulators of FSH secretion. 21<23 In this context, the blunted elevation in follicular phase urinary FSH in premenopausal women with DOR compared with the older perimenopausal controls may reflect a higher level of counterregulatory gonadal hormones, for example, inhibin, activin, and follistatin, and hence a relatively replete ovarian reserve in the younger population compared with the older perimenopausal cohort. This is consistent with the fact that the women with DOR were still cycling regularly, whereas the perimenopausal controls had experienced some cycle irregularity 10 (ie, at least one skipped menstrual period within the 3 mo before enrollment).
The significantly higher urinary E1c level in the chronologically older perimenopausal cohort was previously reported and identified perimenopause as a state of relative estrogen excess. 10,24<28 Conversely, these comparative analyses suggest premenopausal DOR as a state of relative hypoestrogenism compared with the more advanced stage of reproductive aging, that is, perimenopause. Indeed, we have previously identified DOR as a risk of premenopausal bone loss and low bone mass 8 and have suggested relative hypoestrogenism as a pathophysiological mechanism in this regard.
Our findings of significantly more prominent LH surges in the setting of DOR, compared with perimenopause, especially in the light of the observed blunted E1c excretion observed in the former, were unexpected. In contrast to the previously reported failure to elicit an LH surge despite normal estrogen exposure in some perimenopausal women, 29 we observed an exaggerated and protracted urinary LH surge in premenopausal women with DOR in the setting of relative hypoestrogenism. Indeed, a dampening of the positive hypothalamic-pituitary feedback response to estrogen is recognized as a feature of the menopausal transition. However, premenopausal women with DOR displayed robust gonadotropin surges, suggesting an enhanced hypothalamic-pituitary sensitivity to the relatively hypoestrogenic milieu. Thus, women with DOR seem to have hormonal feedback responses that are distinct from both the healthy young women with normal ovarian reserve 9 and a chronologically older cohort of perimenopausal women. The observed differences in the reproductive hormone dynamics between premenopausal women with DOR and the older perimenopausal controls may be attributable, in part, to the residual ovarian reserve in the former, as reflected by regular menstrual cyclicity in all women diagnosed with DOR. Regularly menstruating premenopausal women with DOR may thus be earlier in the process of progressive ovarian senescence compared with the older perimenopausal cohort. Alternatively, chronological differences between the two groups may underlie the observed differences.
Our finding of a protracted LH surge in premenopausal women with DOR is novel and has not been previously re- 30 suggested that the ovarian gonadotropin surgeYattenuating factor plays a role in the negative regulation of pulsatile LH secretion. A decline in gonadotropin surgeYattenuating factor was previously reported both in poor responders to ovarian stimulation and in aging women 31 and hence may not be the unifying mediator for the observed differences in our data. Gonadotropin-releasing hormone (GnRH) pulses were known to stimulate the synthesis and secretion of LH and FSH from the anterior pituitary. Rapid GnRH pulse frequencies of more than one pulse per hour favor LH secretion, whereas slow pulse frequencies of less than one pulse in 2 to 3 hours favor FSH secretion. 32 GnRH/LH secretion in women with DOR may be helpful in elucidating the underlying pathophysiology.
The overall urinary E1c excretion was observed to be significantly lower in premenopausal women with DOR compared with the perimenopausal cohort. The magnitude of this differential in urinary E1c excretion in the two groups is probably influenced, in part, by the relative estrogen excess of perimenopause 10,24<28 and by the relative hypoestrogenism of DOR. 9 Urinary E1c levels are recognized to reliably reflect ovarian estrogen production, as reflected by paired analyses of urine and serum samples. 15 A difference in estrogen metabolic rates between the two groups is also plausible and may theoretically be contributory to the observed group differences in urinary E1c levels, a conjecture that cannot be elaborated upon, given the constraints of our study design. Serum estrogen levels are recognized to relate to body mass, particularly in postmenopausal women. 34 Although differences in body mass may be theorized to influence estrogen metabolites, urinary E1c levels are recognized to reflect ovarian rather than peripheral estrogens 15 and are unlikely to be influenced by body mass index, as has previously been described. 35 Luteal insufficiency is recognized as contributory to the reproductive compromise of aging, 36 and we have previously demonstrated evidence of luteal inefficiency in the context of DOR. 9 The observed luteal Pdg profiles suggest comparable degrees of luteal compromise in the setting of premature (ie, DOR) and age-appropriate (ie, perimenopause) ovarian senescence. Although the underlying pathophysiological mechanisms remain far from clear, based on these observations, one may hypothesize that inadequate luteal progesterone secretion may be a common denominator to the reproductive compromise of aging and what is seen in the context of compromised ovarian reserve, 2,9 a conjecture that merits substantiation by future studies.
The small sample size of our study is an obvious limitation that is a likely contributor to the relatively large standard errors observed in some measurements, such as of LH. This small sample highlights recruitment constraints that are appreciable in studies of infertile women with DOR, an emotionally fragile population that is reluctant to defer pursuit of fertility attempts in favor of participation in clinical research. 37 Although historical perimenopausal controls were used, stored urinary samples were tested using established methods 38, 39 to ensure the stability of hormone levels and consistency in assays. FSH receptor polymorphism is a recognized pathophysiological mechanism for compromised ovarian reserve, albeit only in a subset of the DOR population. 40 This information, unfortunately, was not available for the cohort studied. Finally, an observational study such as this precludes the establishment of any cause-effect relationship; these observations, however, offer meaningful direction for future studies.
CONCLUSIONS
Our data indicate distinct reproductive hormone dynamics in young infertile women with DOR compared with older perimenopausal women. Distinctions (significantly lower E1c in addition to higher amplitude and duration of an LH surge evident in premenopausal women with DOR compared with the perimenopausal cohort) and similarities (comparable luteal Pdg urinary excretion in the two groups) are identified in the urinary reproductive hormone profiles of the two population samples. Further investigations are needed to better appreciate and help disentangle the mechanisms that may underlie the observed differences in the reproductive hormone milieu and better elucidate a place for premenopausal DOR in the paradigm of reproductive aging.
